| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Referees
|
|
|
|
33 |
6 |
p. 595-598
|
artikel
|
| 2 |
Analysis of Immunogenicity Data in the Product Information of Biological Drugs: A Need to Report Immunogenicity Data Systematically
|
Borrega, Rodrigo
|
|
|
33 |
6 |
p. 683-691
|
artikel
|
| 3 |
An Efficient Development Paradigm for Biosimilars
|
Webster, Christopher J.
|
|
|
33 |
6 |
p. 603-611
|
artikel
|
| 4 |
Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar
|
Paek, Kyungyeol
|
|
|
33 |
6 |
p. 661-671
|
artikel
|
| 5 |
Biosimilars: An Opportunity to Update the Product Information of Biological Drugs Regarding their Immunogenicity
|
Borrega, Rodrigo
|
|
|
33 |
6 |
p. 693-695
|
artikel
|
| 6 |
CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms
|
Roselli, Emiliano
|
|
|
33 |
6 |
p. 647-659
|
artikel
|
| 7 |
Delivering on the Promise of Biosimilars
|
Vulto, Arnold G.
|
|
|
33 |
6 |
p. 599-602
|
artikel
|
| 8 |
Different Cardiotoxicity of Palbociclib and Ribociclib in Breast Cancer: Gene Expression and Pharmacological Data Analyses, Biological Basis, and Therapeutic Implications
|
Santoni, Matteo
|
|
|
33 |
6 |
p. 613-620
|
artikel
|
| 9 |
Evolution of the EU Biosimilar Framework: Past and Future
|
Wolff-Holz, Elena
|
|
|
33 |
6 |
p. 621-634
|
artikel
|
| 10 |
Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim
|
Gascon, Pere
|
|
|
33 |
6 |
p. 635-645
|
artikel
|
| 11 |
Steady-State Plasma Concentrations of Polyethylene Glycol (PEG) are Reached in Children and Adults During Once-Weekly Prophylactic Treatment with Nonacog Beta Pegol (N9-GP)
|
Sternebring, Ola
|
|
|
33 |
6 |
p. 673-681
|
artikel
|
Tijdschrift beschrijving